No Picture
News

Ironwood Pharmaceuticals to Present New IW-3300 and Linaclotide Data at Digestive Disease Week® 2022

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the company and its collaborators will present eight studies, including two oral presentations, during the Digestive Disease Week® (DDW) 2022 meeting being […]

No Picture
News

Ethos Asset Management Inc., USA Announces Deal with Ecom Mortgage, Inc., to Grow its Core Mortgage Brokering and Banking Business by Increasing its Assets Under Management

Partnership Provides Long Term Financing to Ecom Mortgage, already established in the industry as a full-service direct mortgage lender with an outstanding team offering expertise in every area of mortgage lending, from purchasing to refinancing […]

No Picture
News

Evofem Presents Data Detailing Fewer Urinary Tract Infections in Women Using Phexxi in the Phase 3 AMPOWER Clinical Trial

5.8% of Women in the AMPOWER Trial Experienced an On-Study Urinary Tract Infection Compared to 11% in the General Population The Post hoc Analysis will be Presented at the 2022 American College of Obstetricians and […]

News

With Aduhelm in tatters, the search is on for Michel Vounatsos’ replacement at Biogen; David Liu, Roger Perlmutter join insitro’s SAB

Michel Vounatsos ? Because of the dearth of Alzheimer’s treatments, Biogen pushed aggressively to cross the regulatory goal line with aducanumab despite early trial wrap-ups and pervasive efficacy questions. The highly controversial approval of Aduhelm, […]

No Picture
News

DATA FROM NOVEL, EXPLORATORY ANALYSIS OF INTERMITTENT VALTOCO® (DIAZEPAM NASAL SPRAY) CIV USE INDICATES MORE THAN TWO-FOLD INCREASE IN MEAN INTERVAL BETWEEN SEIZURE CLUSTERS

Neurelis presents two posters at the 2nd North American Epilepsy Congress (NAEC) highlighting new analysis of change in timing between seizure clusters across 12 months, and final effectiveness and safety data from the Phase 3, […]

No Picture
News

Regulus Therapeutics Announces Timing for First Quarter 2022 Financial Results Webcast and Conference Call

SAN DIEGO, May 5, 2022 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that it will […]

News

Why hungry worms take risks

The worm Caenorhabditis elegans.Click here for a high-resolution image.Credit: Salk Institute LA JOLLA–Whether it’s making rash decisions or feeling grumpy, hunger can make us think and act differently—“hangry,” even. But little is known about how […]

No Picture
News

Petco and Butterfly Collaborate to Bring Cutting-Edge Ultrasound Technology to All Full-Service Veterinary Hospitals in Petco Pet Care Centers

Leading pet health and wellness company, Petco, and digital health innovator, Butterfly, elevate veterinary industry point-of-care standard by increasing pet access to high-quality ultrasound GUILFORD, Conn. and SAN DIEGO, May 5, 2022 /PRNewswire/ — Butterfly […]

No Picture
News

U.S.-MEXICO BORDER PHILANTHROPY PARTNERSHIP AND VENTANILLA DE SALUD AT THE CONSULATE GENERAL OF MEXICO IN SAN DIEGO BEGIN FREE COVID-19 RAPID TESTING AT CROSS BORDER XPRESS

This program is supported by the California Department of Public Health, Office of Binational Border Health, and the COVID-19 Testing Taskforce. SAN DIEGO, May 4, 2022 /PRNewswire/ — A collaboration between the Ventanilla de Salud […]

No Picture
News

Nordson Electronics Solutions Introduces New Helios® System for Dispensing Single-Component Thermal Interface Materials

CARLSBAD, Calif.–(BUSINESS WIRE)–Dispensing thermal interface materials is easier with the new FS-EP1 Fluid Supply/Feeding System One-Gallon Pail Pump for the Helios® dispenser Click here to view original post

No Picture
News

Neurocrine Biosciences Reports First Quarter 2022 Financial Results and Reiterates 2022 Financial Guidance

INGREZZA® (valbenazine) First Quarter Net Product Sales of $303 Million INGREZZA® (valbenazine) 2022 Net Product Sales Guidance Reiterated at $1.25 – $1.35 Billion SAN DIEGO, May 4, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) […]

No Picture
News

 Accelerated Biosciences and Pluristyx Announce Availability of Human Trophoblast Stem Cell (hTSC) Derived iPSCs

CARLSBAD, Calif.–(BUSINESS WIRE)– #acceleratedbio–Accelerated Biosciences, a regenerative medicine innovator of proprietary human trophoblast stem cells (hTSCs), announced an agreement for Pluristyx, Inc., an advanced therapy tools and services biotechnology company, to provide iPSCs derived from […]